Clinical Trial Update: Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating induction therapy with a single high-dose intravenous methotrexate with leucovorin rescue prior to AVONEX treatment in patients with a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Demyelinating Disorders
• Multiple Sclerosis
• Myelitis
• Neuritis
• Optic Neuritis

Drugs mentioned

• Avonex (Interferon beta-1a)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute | Conditions: Demyelinating Disorders, Multiple Sclerosis | Phase 4 | Status: WITHDRAWN